Lb Pharmaceuticals Inc.
Clinical trials sponsored by Lb Pharmaceuticals Inc., explained in plain language.
-
New schizophrenia drug enters final testing phase
Disease control Recruiting nowThis study tests a new medicine called LB 102 to see if it helps reduce symptoms of schizophrenia, such as hallucinations and confused thinking. About 456 adults with acute schizophrenia will receive either LB 102 or a placebo for 6 weeks. The goal is to find a safe and effective…
Phase: PHASE3 • Sponsor: LB Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New pill aims to lift bipolar depression in just 6 weeks
Symptom relief Recruiting nowThis study tests an experimental drug called LB-102 to see if it can safely reduce depression in people with bipolar I disorder. About 320 adults will be randomly assigned to receive either the drug or a placebo for 6 weeks. The main goal is to measure changes in depression sympt…
Phase: PHASE2 • Sponsor: LB Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 18, 2026 12:02 UTC